19-3927773-G-A

Variant summary

Our verdict is . The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_033064.5(ATCAY):​c.*3181G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.389 in 152,180 control chromosomes in the GnomAD database, including 12,023 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.39 ( 12010 hom., cov: 32)
Exomes 𝑓: 0.52 ( 13 hom. )

Consequence

ATCAY
NM_033064.5 3_prime_UTR

Scores

3

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -2.64

Publications

14 publications found
Variant links:
Genes affected
ATCAY (HGNC:779): (ATCAY kinesin light chain interacting caytaxin) This gene encodes a neuron-restricted protein that contains a CRAL-TRIO motif common to proteins that bind small lipophilic molecules. Mutations in this gene are associated with cerebellar ataxia, Cayman type. [provided by RefSeq, Jul 2008]
ATCAY Gene-Disease associations (from GenCC):
  • Cayman type cerebellar ataxia
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia, Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_033064.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98).
BP6
Variant 19-3927773-G-A is Benign according to our data. Variant chr19-3927773-G-A is described in ClinVar as Benign. ClinVar VariationId is 329202.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.598 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_033064.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATCAY
NM_033064.5
MANE Select
c.*3181G>A
3_prime_UTR
Exon 13 of 13NP_149053.1A0A0S2Z5T8

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATCAY
ENST00000450849.7
TSL:1 MANE Select
c.*3181G>A
3_prime_UTR
Exon 13 of 13ENSP00000390941.1Q86WG3-1

Frequencies

GnomAD3 genomes
AF:
0.389
AC:
59088
AN:
151958
Hom.:
11991
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.397
Gnomad AMI
AF:
0.341
Gnomad AMR
AF:
0.494
Gnomad ASJ
AF:
0.391
Gnomad EAS
AF:
0.569
Gnomad SAS
AF:
0.616
Gnomad FIN
AF:
0.335
Gnomad MID
AF:
0.497
Gnomad NFE
AF:
0.338
Gnomad OTH
AF:
0.409
GnomAD4 exome
AF:
0.519
AC:
54
AN:
104
Hom.:
13
Cov.:
0
AF XY:
0.487
AC XY:
39
AN XY:
80
show subpopulations
African (AFR)
AF:
0.250
AC:
1
AN:
4
American (AMR)
AF:
0.500
AC:
1
AN:
2
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.750
AC:
3
AN:
4
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.533
AC:
49
AN:
92
Other (OTH)
AF:
0.00
AC:
0
AN:
2
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.389
AC:
59141
AN:
152076
Hom.:
12010
Cov.:
32
AF XY:
0.397
AC XY:
29483
AN XY:
74348
show subpopulations
African (AFR)
AF:
0.397
AC:
16458
AN:
41492
American (AMR)
AF:
0.495
AC:
7556
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
0.391
AC:
1357
AN:
3470
East Asian (EAS)
AF:
0.568
AC:
2932
AN:
5160
South Asian (SAS)
AF:
0.616
AC:
2973
AN:
4824
European-Finnish (FIN)
AF:
0.335
AC:
3549
AN:
10586
Middle Eastern (MID)
AF:
0.514
AC:
151
AN:
294
European-Non Finnish (NFE)
AF:
0.338
AC:
22997
AN:
67972
Other (OTH)
AF:
0.406
AC:
858
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1861
3722
5582
7443
9304
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
564
1128
1692
2256
2820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.364
Hom.:
28078
Bravo
AF:
0.398
Asia WGS
AF:
0.602
AC:
2088
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Cayman type cerebellar ataxia (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.98
CADD
Benign
0.12
DANN
Benign
0.53
PhyloP100
-2.6
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.